154 related articles for article (PubMed ID: 15945588)
41. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
Lawlor BA
J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
[TBL] [Abstract][Full Text] [Related]
42. [Behavioural and psychological symptoms of dementia (BPSD): pharmacological management].
Gillabert C; Desmeules J; Vogt-Ferrier N; Dayer P
Rev Med Suisse; 2006 Apr; 2(61):970-5. PubMed ID: 16686329
[TBL] [Abstract][Full Text] [Related]
43. Risperidone versus olanzapine for schizophrenia.
Jayaram MB; Hosalli P
Cochrane Database Syst Rev; 2005 Apr; (2):CD005237. PubMed ID: 15846745
[TBL] [Abstract][Full Text] [Related]
44. Pharmacological treatment of Alzheimer's Disease.
Bianchetti A; Ranieri P; Margiotta A; Trabucchi M
Aging Clin Exp Res; 2006 Apr; 18(2):158-62. PubMed ID: 16702787
[TBL] [Abstract][Full Text] [Related]
45. Managing the behavioral and psychological signs and symptoms of dementia.
Finkel SI
Int Clin Psychopharmacol; 1997 Sep; 12 Suppl 4():S25-8. PubMed ID: 9352343
[TBL] [Abstract][Full Text] [Related]
46. Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): study protocol for a cluster-randomised controlled trial.
Richter C; Berg A; Fleischer S; Köpke S; Balzer K; Fick EM; Sönnichsen A; Löscher S; Vollmar HC; Haastert B; Icks A; Dintsios CM; Mann E; Wolf U; Meyer G
Implement Sci; 2015 Jun; 10():82. PubMed ID: 26037324
[TBL] [Abstract][Full Text] [Related]
47. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
48. Antipsychotics for delirium.
Lonergan E; Britton AM; Luxenberg J; Wyller T
Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
[TBL] [Abstract][Full Text] [Related]
49. Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients.
Edell WS; Tunis SL
Am J Geriatr Psychiatry; 2001; 9(3):289-97. PubMed ID: 11481138
[TBL] [Abstract][Full Text] [Related]
50. Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia.
Yury CA; Fisher JE
Psychother Psychosom; 2007; 76(4):213-8. PubMed ID: 17570959
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of risperidone for treating patients with behavioral and psychological symptoms of dementia.
Wancata J
Int Psychogeriatr; 2004 Mar; 16(1):107-15. PubMed ID: 15191000
[TBL] [Abstract][Full Text] [Related]
52. [Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].
Zuidema SU; van Iersel MB; Koopmans RT; Verhey FR; Olde Rikkert MG
Ned Tijdschr Geneeskd; 2006 Jul; 150(28):1565-73. PubMed ID: 16886695
[TBL] [Abstract][Full Text] [Related]
53. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.
Sink KM; Holden KF; Yaffe K
JAMA; 2005 Feb; 293(5):596-608. PubMed ID: 15687315
[TBL] [Abstract][Full Text] [Related]
54. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
55. Increase in mortality rate in patients with dementia treated with atypical antipsychotics: a cohort study in outpatients in Central Italy.
Piersanti M; Capannolo M; Turchetti M; Serroni N; De Berardis D; Evangelista P; Costantini P; Orsini A; Rossi A; Maggio R
Riv Psichiatr; 2014; 49(1):34-40. PubMed ID: 24572582
[TBL] [Abstract][Full Text] [Related]
56. Neuroleptics for behavioral symptoms of dementia.
Reynolds PL; Strayer SM
J Fam Pract; 2000 Jan; 49(1):78-9. PubMed ID: 10678345
[No Abstract] [Full Text] [Related]
57. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
58. New generation antipsychotics for first episode schizophrenia.
Rummel C; Hamann J; Kissling W; Leucht S
Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012
[TBL] [Abstract][Full Text] [Related]
59. Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
Marras C; Herrmann N; Anderson GM; Fischer HD; Wang X; Rochon PA
Am J Geriatr Pharmacother; 2012 Dec; 10(6):381-9. PubMed ID: 23217531
[TBL] [Abstract][Full Text] [Related]
60. Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance.
Ostuzzi G; Barbui C; Hanlon C; Chatterjee S; Eaton J; Jones L; Silove D; Ventevogel P
BMC Med; 2017 Dec; 15(1):197. PubMed ID: 29224570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
